Publikationen von Lüke, Florian

Bernardi, Christine, Wolff, Daniel , Lüke, Florian , Hies, Johannes, Hallowell, Nina, Horn, Ruth, Seitz, Frederike, Heudobler, Daniel und Hermann-Johns, Anne (2024) “Uninformed consent” in clinical trials with cancer patients: A qualitative analysis of patients’ and support persons’ communication experiences and needs. Patient Education and Counseling 122, S. 108144.

Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Gerner, Christopher , Reichle, Albrecht und Heudobler, Daniel (2024) Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity. Frontiers in Oncology 13.

Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht und Heudobler, Daniel (2023) Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance. Cancers 16 (1), S. 180.

Fante, Matthias A., Harrer, Dennis C. , Zartner, Barbara, Lüke, Florian , Mayer, Stephanie, Menhart, Karin , Reichle, Albrecht , Herr, Wolfgang, Vogelhuber, Martin und Heudobler, Daniel (2023) All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma. Frontiers in Oncology 13.

Scheiter, Alexander , Hierl, Frederik, Lüke, Florian , Keil, Felix , Heudobler, Daniel , Einhell, Sabine, Klier-Richter, Margit, Konstandin, Nikola P., Weber, Florian , Scheiter, Andrea, Kandulski, Arne, Schlosser, Sophie , Cosma, Lidia-Sabina, Tews, Hauke, Weiss, Andreas R. R. , Grube, Matthias, Bumes, Elisabeth , Hau, Peter , Proescholdt, Martin A. , Steger, Felix, Troeger, Anja, Haferkamp, Sebastian , Reibenspies, Lucas E., Schnabel, Marco J., Schulz, Christian , Drexler, Konstantin, Hatzipanagiotou, Maria E., Seitz, Stephan, Klinkhammer-Schalke, Monika, Unberath, Philipp, Calvisi, Diego F. , Pukrop, Tobias , Dietmaier, Wolfgang, Evert, Matthias und Utpatel, Kirsten (2022) Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. British Journal of Cancer.

Lüke, Florian, Haller, Florian, Utpatel, Kirsten, Krebs, Markus, Meidenbauer, Norbert, Scheiter, Alexander , Spoerl, Silvia, Heudobler, Daniel , Sparrer, Daniela, Kaiser, Ulrich, Keil, Felix , Schubart, Christoph D., Tögel, Lars, Einhell, Sabine, Dietmaier, Wolfgang, Huss, Ralf, Dintner, Sebastian, Sommer, Sebastian, Jordan, Frank, Goebeler, Maria-Elisabeth, Metz, Michaela, Haake, Diana, Scheytt, Mithun, Gerhard-Hartmann, Elena, Maurus, Katja, Brändlein, Stephanie, Rosenwald, Andreas, Hartmann, Arndt, Märkl, Bruno, Einsele, Hermann , Mackensen, Andreas, Herr, Wolfgang, Kunzmann, Volker, Bargou, Ralf, Beckmann, Matthias W., Pukrop, Tobias , Trepel, Martin, Evert, Matthias, Claus, Rainer und Kerscher, Alexander Nikolaus (2022) Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium. Cancers 14 (20), S. 5040.

Scheiter, Alexander , Hierl, Frederik, Winkel, Ingrid, Keil, Felix, Klier-Richter, Margit, Coulouarn, Cédric, Lüke, Florian, Kandulski, Arne, Evert, Matthias, Dietmaier, Wolfgang, Calvisi, Diego F. und Utpatel, Kirsten (2022) Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities. Journal of Personalized Medicine 12 (8), S. 1270.

Lüke, Florian , Harrer, Dennis Christoph, Pantziarka, Pan , Pukrop, Tobias , Ghibelli, Lina, Gerner, Christopher , Reichle, Albrecht und Heudobler, Daniel (2022) Drug Repurposing by Tumor Tissue Editing. Frontiers in Oncology 2022 (12), S. 900985.

Heudobler, Daniel, Harrer, Dennis Christoph, Lüke, Florian , Einspieler, Ingo, Menhart, Karin, Hellwig, Dirk , Utpatel, Kirsten , Herr, Wolfgang und Reichle, Albrecht (2022) Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature. Frontiers in Oncology 2022 (12), S. 1-7.

Harrer, Dennis C., Jakob, Marcus, Vogelhuber, Martin, Lüke, Florian, Utpatel, Kirsten, Corbacioglu, Selim, Herr, Wolfgang, Reichle, Albrecht und Heudobler, Daniel (2022) Biomodulatory therapy induces durable remissions in multi-system Langerhans cell histiocytosis. Leukemia & Lymphoma 63 (12), S. 2858-2868. Volltext nicht vorhanden.

Siska, Peter J., Decking, Sonja-Maria, Babl, Nathalie, Matos, Carina, Bruss, Christina, Singer, Katrin, Klitzke, Jana, Schön, Marian, Simeth, Jakob , Köstler, Josef, Siegmund, Heiko, Ugele, Ines, Paulus, Michael, Dietl, Alexander, Kolodova, Kristina, Steines, Louisa , Freitag, Katharina, Peuker, Alice, Schönhammer, Gabriele, Raithel, Johanna, Graf, Bernhard, Geismann, Florian, Lubnow, Matthias, Mack, Matthias, Hau, Peter, Bohr, Christopher, Burkhardt, Ralph , Gessner, Andre, Salzberger, Bernd, Wagner, Ralf, Hanses, Frank, Hitzenbichler, Florian, Heudobler, Daniel, Lüke, Florian, Pukrop, Tobias, Herr, Wolfgang, Wolff, Daniel, Spang, Rainer, Poeck, Hendrik, Hoffmann, Petra, Jantsch, Jonathan, Brochhausen, Christoph, Lunz, Dirk, Rehli, Michael, Kreutz, Marina und Renner, Kathrin (2021) Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone. Journal of Clinical Investigation 131 (22), e148225. Zugang zum Volltext eingeschränkt.

Gerthofer, Valeria, Scheiter, Alexander , Lüke, Florian , Keil, Felix , Utpatel, Kirsten , Pöhmerer, Laura-Maria-Giovanna, Seitz, Johannes, Niessen, Christoph, Ignatov, Atanas , Dietmaier, Wolfgang, Calvisi, Diego F., Evert, Matthias, Ortmann, Olaf und Seitz, Stephan (2021) STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy. JCO Precision Oncology 2021 (5), S. 1507-1513.

Lüke, Florian, Harrer, Dennis C., Menhart, Karin, Wolff, Daniel, Holler, Ernst, Hellwig, Dirk, Herr, Wolfgang, Grube, Matthias, Vogelhuber, Martin, Reichle, Albrecht und Heudobler, Daniel (2021) Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease. Frontiers in Pharmacology 12 (599561), S. 1-8.

Lüke, Florian, Harrer, Dennis C., Hahn, Joachim, Grube, Matthias, Pukrop, Tobias, Herr, Wolfgang, Reichle, Albrecht und Heudobler, Daniel (2021) Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy. Frontiers in Pharmacology 2021 (12), S. 599552.

Heudobler, Daniel, Schulz, Christian , Fischer, Jürgen R., Staib, Peter, Wehler, Thomas, Südhoff, Thomas, Schichtl, Thomas, Wilke, Jochen, Hahn, Joachim, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Pukrop, Tobias , Herr, Wolfgang, Held, Swantje, Beckers, Kristine, Bouche, Gauthier und Reichle, Albrecht (2021) A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung). Frontiers in Pharmacology 12 (599598), S. 1-10.

Scheiter, Alexander, Keil, Felix, Lüke, Florian, Grosse, Jirka, Verloh, Niklas , Opitz, Sabine, Schlosser, Sophie, Kandulski, Arne, Pukrop, Tobias, Dietmaier, Wolfgang, Evert, Matthias, Calvisi, Diego F. und Utpatel, Kirsten (2021) Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy. Current Oncology 2021 (28), S. 1161-1169. (Eingereicht)

Lubnow, Matthias , Schmidt, Barbara, Fleck, Martin, Salzberger, Bernd, Müller, Thomas, Peschel, Georg, Schneckenpointner, Roland, Lange, Tobias, Hitzenbichler, Florian , Kieninger, Martin, Lunz, Dirk, Graf, Bernhard, Brochhausen, Christoph, Weber, Florian, Lüke, Florian, Peterhoff, David, Schuster, Philipp, Hiergeist, Andreas, Offner, Robert, Hehr, Ute, Wallner, Stefan, Hanses, Frank , Schmid, Stephan, Weigand, Kilian, Geismann, Florian , Poeck, Hendrik, Pukrop, Tobias, Evert, Matthias, Gessner, Andre, Burkhardt, Ralph , Herr, Wolfgang, Maier, Lars S. und Heudobler, Daniel (2021) Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson’s disease: Balancing immunosuppression. International Journal of Infectious Diseases 103 (2021), S. 624-627.

Hücker, Sarah M., Fehlmann, Tobias, Werno, Christian, Weidele, Kathrin, Lüke, Florian, Schlenska-Lange, Anke, Klein, Christoph A., Keller, Andreas und Kirsch, Stefan (2021) Single-cell microRNA sequencing method comparison and application to cell lines and circulating lung tumor cells. Nature Communications 12 (1). Volltext nicht vorhanden.

Lüke, Florian , Orsó, Evelyn , Kirsten, Jana, Poeck, Hendrik, Grube, Matthias, Wolff, Daniel, Burkhardt, Ralph , Lunz, Dirk, Lubnow, Matthias, Schmidt, Barbara, Hitzenbichler, Florian, Hanses, Frank, Salzberger, Bernd , Evert, Matthias, Herr, Wolfgang, Brochhausen, Christoph, Pukrop, Tobias, Reichle, Albrecht und Heudobler, Daniel (2020) Coronavirus disease 2019 induces multi‐lineage, morphologic changes in peripheral blood cells. eJHaem 1 (1), S. 376-383.

Heudobler, Daniel, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Pukrop, Tobias , Herr, Wolfgang, Gerner, Christopher , Pantziarka, Pan, Ghibelli, Lina und Reichle, Albrecht (2019) Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction. Frontiers in Oncology 9 (1408), S. 1-22.

Lüke, Florian (2019) Einfluss des PPARγ Agonisten Pioglitazon auf murine Knochenmarksmakrophagen im Kontext des Mammakarzinoms. Dissertation, Universität Regensburg.

Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Thomas, Simone, Pukrop, Tobias, Hackl, Christina, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher und Reichle, Albrecht (2018) Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis. Frontiers in Pharmacology 9 (1357), S. 1-26.

Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Pukrop, Tobias, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher und Reichle, Albrecht (2018) Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue. International Journal of Molecular Sciences 19 (11), S. 3540.